Vimarsana
Biggest News Aggregation in the World

Page 3 - Uses Thereof News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Uses Thereof. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Uses Thereof Today - Breaking & Trending Today

Epps, Lee honored by National Academy of Inventors - Vimarsana News

Epps, Lee honored by National Academy of Inventors

NAI Fellows Program recognizes outstanding inventions with tangible impact

Source: udel.edu
EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation - Vimarsana News

EQS-Adhoc: RELIEF THERAPEUTICS Holding AG: Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00

EQS-Adhoc: Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation - Vimarsana News

EQS-Adhoc: Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation

EQS Group-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Acer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation 07-Oct-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsibl...

Proactive Investors China - The web's leading portal for China stocks - Orthocell granted key US divisional patent for CelGro® - Vimarsana News

Proactive Investors China - The web's leading portal for China stocks - Orthocell granted key US divisional patent for CelGro®

2021-02-15 by Proactive Australia Orthocell Ltd (ASX:OCC) has received a new US divisional patent for CelGro® that covers the method of manufacture of collagen medical devices and as an aid in the surgical repair of soft tissue injuries. The patents entitled ‘Method for Producing a Collagen Membrane and Uses Thereof' provides additional important intellectual property (IP) to protect the CelGro® platform for soft tissue regeneration and repair applications and expires in June 2033. Orthocell has already been granted patents for CelGro® in the US, Canada, Europe, China, Japan, Singapore,...

Oil-Dri Announces Patent in Korea for Novel Mineral-Based Feed Additive Formulation for Modern ... - Vimarsana News

Oil-Dri Announces Patent in Korea for Novel Mineral-Based Feed Additive Formulation for Modern ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com